相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Selective inhibition of phosphodiesterase 4D increases tau phosphorylation at Ser214 residue
Viviana Villa et al.
BIOFACTORS (2022)
Cyclic GMP and PKG Signaling in Heart Failure
Genri Numata et al.
FRONTIERS IN PHARMACOLOGY (2022)
Protein kinase G phosphorylates the Alzheimer's disease-associated tau protein at distinct Ser/Thr sites
Giulia Montalto et al.
BIOFACTORS (2021)
A review on the role of tau and stathmin in gastric cancer metastasis
Bahareh Zarin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease
Niels D. Prins et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease
Raymond S. Turner et al.
ANNALS OF NEUROLOGY (2020)
Beneficial effects of low-dose lithium on cognitive ability and pathological alteration of Alzheimer's disease transgenic mice model
Meng Liu et al.
NEUROREPORT (2020)
Functions and regulation of the serine/threonine protein kinase CK1 family: moving beyond promiscuity
Luke J. Fulcher et al.
BIOCHEMICAL JOURNAL (2020)
Emerging Evidences for an Implication of the Neurodegeneration-Associated Protein TAU in Cancer
Stephanie Papin et al.
BRAIN SCIENCES (2020)
Phosphorylation of Tau and alpha-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson's Disease
Shanshan Hu et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2020)
PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress
Mark J. Ranek et al.
NATURE (2019)
Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial
Orestes V. Forlenza et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Efficacy and Safety of Glycogen Synthase Kinase 3 Inhibitors for Alzheimer's Disease: A Systematic Review and Meta-Analysis
Shinji Matsunaga et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Nilotinib in the treatment of chronic myeloid leukemia
Tomasz Sacha et al.
FUTURE ONCOLOGY (2019)
Forskolin Induces Hyperphosphorylation of Tau Accompanied by Cell Cycle Reactivation in Primary Hippocampal Neurons
Hai-Hong Wang et al.
MOLECULAR NEUROBIOLOGY (2018)
Tau clearance improves astrocytic function and brain glutamate-glutamine cycle
Michaeline L. Hebron et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Local protein kinase A action proceeds through intact holoenzymes
F. Donelson Smith et al.
SCIENCE (2017)
Up-regulation of casein kinase 1ε is involved in tau pathogenesis in Alzheimer's disease
Caoyi Chen et al.
SCIENTIFIC REPORTS (2017)
The many faces of compartmentalized PKA signalosomes
Omar Torres-Quesada et al.
CELLULAR SIGNALLING (2017)
Tau in physiology and pathology
Yipeng Wang et al.
NATURE REVIEWS NEUROSCIENCE (2016)
cAMP-dependent protein kinase (PKA) complexes probed by complementary differential scanning fluorimetry and ion mobility-mass spectrometry
Dominic P. Byrne et al.
BIOCHEMICAL JOURNAL (2016)
Neuroprotective Mechanisms Mediated by CDK5 Inhibition
Gohar Mushtaq et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
mTor mediates tau localization and secretion: Implication for Alzheimer's disease
Zhi Tang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Tau stabilizes microtubules by binding at the interface between tubulin heterodimers
Harindranath Kadavath et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Mechanisms of cyclic AMP/protein kinase A- and glucocorticoid-mediated apoptosis using S49 lymphoma cells as a model system
Malik M. Keshwani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A Phase II Trial of Tideglusib in Alzheimer's Disease
Simon Lovestone et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial
Guenter U. Hoeglinger et al.
MOVEMENT DISORDERS (2014)
A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions
Marie Violet et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Regulation of alternative splicing of tau exon 10
Wei Qian et al.
NEUROSCIENCE BULLETIN (2014)
Physiological and pathological phosphorylation of tau by Cdk5
Taeko Kimura et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
Tyrosine kinase inhibition increases functional parkin-Beclin-1 interaction and enhances amyloid clearance and cognitive performance
Irina Lonskaya et al.
EMBO MOLECULAR MEDICINE (2013)
AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans
Biljana Georgievska et al.
JOURNAL OF NEUROCHEMISTRY (2013)
The importance of tau phosphorylation for neurodegenerative diseases
Wendy Noble et al.
FRONTIERS IN NEUROLOGY (2013)
Regulation of Mitochondrial Transport and Inter-Microtubule Spacing by Tau Phosphorylation at the Sites Hyperphosphorylated in Alzheimer's Disease
Kourosh Shahpasand et al.
JOURNAL OF NEUROSCIENCE (2012)
Lithium Treatment of APPSwDI/NOS2-/- Mice Leads to Reduced Hyperphosphorylated Tau, Increased Amyloid Deposition and Altered Inflammatory Phenotype
Tiffany L. Sudduth et al.
PLOS ONE (2012)
Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration
Eva-Maria Mandelkow et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Nuclear Tau, a Key Player in Neuronal DNA Protection
Audrey Sultan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Membrane Association Facilitates Degradation and Cleavage of the Cyclin-Dependent Kinase 5 Activators p35 and p39
Seiji Minegishi et al.
BIOCHEMISTRY (2010)
Phosphorylation of Tau at Thr212, Thr231, and Ser262 Combined Causes Neurodegeneration
Alejandra D. Alonso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits
Elena Gomez de Barreda et al.
NEUROBIOLOGY OF DISEASE (2010)
Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration
Brian R. Hoover et al.
NEURON (2010)
Validating GSK3 as an in vivo target of lithium action
W. Timothy O'Brien et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
The Microtubule-Associated Protein Tau is Also Phosphorylated on Tyrosine
Thibaud Lebouvier et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Phosphorylated Tau Interacts with c-Jun N-terminal Kinase-interacting Protein 1 (JIP1) in Alzheimer Disease
Lars M. Ittner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A novel GSK-3 beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
L. Sereno et al.
NEUROBIOLOGY OF DISEASE (2009)
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Diane P. Hanger et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Structural Polymorphism of 441-Residue Tau at Single Residue Resolution
Marco D. Mukrasch et al.
PLOS BIOLOGY (2009)
The natively unfolded character of Tau and its aggregation to Alzheimer-like paired helical filaments
Sadasivam Jeganathan et al.
BIOCHEMISTRY (2008)
A feasibility and tolerability study of lithium in Alzheimer's disease
Alastair Macdonald et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome
Jianhua Shi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Tau-based treatment strategies in neurodegenerative diseases
Anja Schneider et al.
NEUROTHERAPEUTICS (2008)
Differential regulation of dynein and kinesin motor proteins by tau
Ram Dixit et al.
SCIENCE (2008)
Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention
K. Iqbal et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis
Diane P. Hanger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia
Emmanuel Planel et al.
JOURNAL OF NEUROSCIENCE (2007)
Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau
D. R. Williams
INTERNAL MEDICINE JOURNAL (2006)
The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation
Florian Plattner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Tau phosphorylation, aggregation, and cell toxicity
J. Avila et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2006)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
The casein kinase I family:: participation in multiple cellular processes in eukaryotes
U Knippschild et al.
CELLULAR SIGNALLING (2005)
Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576
NB Chauhan et al.
NEUROPHARMACOLOGY (2005)
Glycogen synthase kinase 3β induces caspase-cleaved tau aggregation in situ
JH Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK)
H Yoshida et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals
T Arendt et al.
JOURNAL OF NEUROSCIENCE (2003)
Process outgrowth of oligodendrocytes is promoted by interaction of Fyn kinase with the cytoskeletal protein Tau
C Klein et al.
JOURNAL OF NEUROSCIENCE (2002)
Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease
JC Augustinack et al.
ACTA NEUROPATHOLOGICA (2002)
Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis
C Atzori et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments
AD Alonso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The protein kinase Cdk5 -: Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology
RB Maccioni et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies
I Ferrer et al.
JOURNAL OF NEURAL TRANSMISSION (2001)
Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease
XW Zhu et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
L Buée et al.
BRAIN RESEARCH REVIEWS (2000)
Role of phosphorylation in the conformation of τ peptides implicated in Alzheimer's disease
NL Daly et al.
BIOCHEMISTRY (2000)
分享论文
